ストックスクリーナーアプリを入手
1.02
0.99%
0.01
アフターアワーズ：
1.04
0.02
+1.96%
前日終値:
$1.01
開ける：
$1.02
24時間の取引高:
2.62M
Relative Volume:
2.37
時価総額：
$92.13M
収益：
$70.14M
当期純損益:
$-76.24M
株価収益率:
-0.9189
EPS:
-1.11
ネットキャッシュフロー:
$-57.06M
1週間 パフォーマンス:
-4.67%
1か月 パフォーマンス:
-29.17%
6か月 パフォーマンス:
-59.36%
1年 パフォーマンス:
-66.45%
1日の値動き範囲:
$0.97
$1.085
1週間の範囲:
$0.97
$1.24
52週間の値動き範囲:
$0.97
$3.87
Codexis Inc Stock (CDXS) Company Profile
Compare CDXS vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
1.02 | 91.23M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-19 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-05-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-29 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-11-07 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-08-07 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | 再開されました | Piper Sandler | Overweight |
| 2022-03-02 | 再開されました | Cowen | Outperform |
| 2021-04-12 | 開始されました | Piper Sandler | Overweight |
| 2021-03-01 | 開始されました | Stifel | Buy |
| 2021-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-10 | 開始されました | The Benchmark Company | Buy |
| 2019-01-17 | アップグレード | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | 開始されました | Stephens | Overweight |
| 2017-10-13 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-31 | 開始されました | Jefferies | Buy |
| 2017-01-26 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Codexis Inc (CDXS) 最新ニュース
CDXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
[Form 4] CODEXIS, INC. Insider Trading Activity - Stock Titan
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 - GlobeNewswire
5,280-share RSU vesting sale at CDXS (NASDAQ: CDXS) - Stock Titan
Codexis Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Codexis (CDXS) Projected to Post Earnings on Thursday - MarketBeat
Is Codexis (NASDAQ:CDXS) Weighed On By Its Debt Load? - 富途牛牛
Codexis to Participate in TD Cowen 46th Annual Health Care Conference - The Manila Times
What makes Codexis Inc. stock attractive to growth fundsMarket Activity Report & Weekly High Return Forecasts - mfd.ru
What’s next for Codexis Inc. stock2025 Historical Comparison & Risk Managed Investment Entry Signals - mfd.ru
Positive Sentiment Still Eludes Codexis, Inc. (NASDAQ:CDXS) Following 29% Share Price Slump - simplywall.st
Macro Review: Does Codexis Inc offer margin of safetyGlobal Markets & Precise Buy Zone Identification - baoquankhu1.vn
Does Codexis Inc. stock trade at a discount to peersWeekly Investment Summary & Free Growth Oriented Trading Recommendations - mfd.ru
Codexis (CDXS) Achieves ISO 9001:2015 Certification - GuruFocus
Codexis Inc. Achieves ISO 9001:2015 Certification for Quality Management Excellence - Quiver Quantitative
What Codexis’ new ISO 9001 status means for enzyme buyers - Stock Titan
Codexis Achieves ISO 9001:2015 Certification - GlobeNewswire
Analysts Expect Breakeven For Codexis, Inc. (NASDAQ:CDXS) Before Long - Yahoo Finance
RSI Check: What makes Codexis Inc stock attractive todayQuarterly Trade Report & Technical Confirmation Trade Alerts - baoquankhu1.vn
Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com
Biofuel Enzymes Market Set to Soar: Innovations Driving - openPR.com
Aberdeen Group plc Expands Stake in Codexis Inc with Significant Share Acquisition - GuruFocus
MACD Signal: Will Codexis Inc benefit from rising consumer demandMarket Performance Recap & Daily Price Action Insights - baoquankhu1.vn
Moving Averages: What are Codexis Incs recent SEC filings showingQuarterly Trade Summary & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug PreEarnings: What is DYCQRs book value per shareWeekly Investment Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Dividend Watch: Is Codexis Inc. stock vulnerable to regulatory risks2025 Sector Review & Daily Momentum Trading Reports - Bộ Nội Vụ
Codexis and Axolabs Partner to Advance Enzymatic RNA Manufacturing - Contract Pharma
How Codexis Inc. stock reacts to Fed rate cutsShare Buyback & Smart Swing Trading Alerts - ulpravda.ru
Codexis CSO Stefan Lutz sells $7949 in shares By Investing.com - Investing.com Nigeria
Codexis CSO Stefan Lutz sells $7949 in shares - Investing.com
Is Codexis Inc. stock safe for conservative investorsJuly 2025 Short Interest & Safe Entry Momentum Tips - Улправда
Codexis (CDXS) Partners with Axolabs for Innovative RNA Manufact - GuruFocus
New partnership tests greener way to mass-produce RNA medicines - Stock Titan
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - Yahoo Finance
Q3 2025 Codexis Inc Earnings Call Transcript - GuruFocus
Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com
Codexis strengthens board with biotech veteran Arthur Levin - MSN
Will Codexis Inc. stock benefit from green energy trendsJuly 2025 Levels & Free Weekly Watchlist of Top Performers - DonanımHaber
Opaleye Management Inc. Reduces Stake in Codexis Inc. - GuruFocus
How Codexis Inc. stock reacts to job market dataPortfolio Profit Report & Expert-Curated Trade Recommendations - Улправда
Opaleye management sells Codexis (CDXS) shares worth $877,846 By Investing.com - Investing.com Nigeria
Opaleye management sells Codexis (CDXS) shares for $1.87 million By Investing.com - Investing.com South Africa
Opaleye management sells Codexis (CDXS) shares for $1.87 million - Investing.com
Codexis : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - marketscreener.com
Opaleye management sells Codexis (CDXS) shares worth $877,846 - Investing.com
MACD Signal: Why Codexis Inc stock could see breakout soonJuly 2025 Trade Ideas & AI Enhanced Trading Alerts - moha.gov.vn
Specialty Enzymes Market size to cross $12.2 Billion by 2035 | - openPR.com
Perhaps timely catching Codexis Inc (CDXS) would be a good idea - Setenews
Is Codexis Inc. stock supported by strong fundamentalsTrade Risk Report & Verified Technical Signals - Newser
Codexis Inc (CDXS) 財務データ
収益
当期純利益
現金流量
EPS
2.90%
2.73%
大文字化:
|
ボリューム (24 時間):